Type 1 Diabetes Trial, Recruiting NCT07027995 Sponsor: Ohio State University Condition: Type 1 Diabetes
Back to Type 1 Diabetes

Type 1 Diabetes Trial, Recruiting

NCT07027995
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with at least one of the following: high blood pressure, type 2 diabetes, high cholesterol, chronic kidney disease, and/or metabolic syndrome.
  • You are 18 years of age or older at the time of signing the consent form.
  • You have reliable transportation to attend in-person exercise sessions.
  • You have access to a device that can connect to the internet (such as a smartphone, tablet, or computer).
  • You are comfortable with ordering groceries online, receiving food deliveries at home, and receiving nutrition advice.
  • Your home address is eligible for Instacart grocery delivery (for example, you live in a regular home, not an institutional facility).
  • You are willing to use a personal credit card as a backup payment method on Instacart if needed.
  • You are able to speak English, in order to take part in the program and give your consent.
  • You have been prescribed a GLP-1 medication by your doctor (a type of medication used for conditions like type 2 diabetes or weight management).

Who may not be able to join:

  • You have a condition that affects how your body digests food or absorbs nutrients — for example, you have had surgery to remove part of your digestive system, have had certain brain surgeries affecting thinking, or have had weight-loss (bariatric) surgery.
  • You have a mental health condition (such as schizophrenia, bipolar disorder, or severe depression) that is not well-managed or controlled with treatment, as decided by the study team.
  • You have a family history of certain cancers, such as multiple endocrine neoplasia or medullary thyroid carcinoma (confirm with trial site).
  • You have an active digestive illness such as Celiac disease, irritable bowel syndrome, or a condition causing long-term poor nutrient absorption.
  • You have other medical or psychiatric conditions that the study doctor believes could put you at risk by participating.
  • Your kidneys are not functioning well enough, based on a specific blood test result (eGFR below 60 — confirm with trial site).
  • There is any other reason the study doctor believes you may not be able to fully participate.
  • You have taken part in another nutrition or behavior-based program or trial in the past 3 months (such as a diabetes education program or bariatric program).
  • You are currently pregnant or planning to become pregnant during the study.
  • You are not willing to provide urine, blood, or stool samples as part of the study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Colleen K Spees, PhD, MEd, RD, Ohio State University

Phone: 9083344689

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ohio State University
Registry
ClinicalTrials.gov
Start date
14 January 2026
Est. completion
1 November 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

GLP-1 RA discontinuation rates

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov